Prolotherapy 3

State of the Art Prolotherapy Theatre

Prolotherapy 1

Sclerosant Injections to Ligaments

Prolotherapy 2

Reduces the Risk of Recurring Back Pain

Prolotherapy 4

Neural Prolotherapy

Prolotherapy Research

Published Audits/Case Series

Case Study 1 - Results
The one year outcomes from this audit, with 58% of patients reporting good benefit, would suggest that prolotherapy is a worthwhile intervention in those patients with confirmed sacroiliac joint pain who have failed to get long term relief from corticosteroid injection.

Source
Chakraverty R, Dias R. Audit of conservative management of chronic low back pain in a secondary care setting – Part I: Facet joint and sacroiliac joint interventions. Acupuncture in Medicine 2004; 22(4):207-213.

Case Study 2 - Results
One hundred and ninety (190) patients were treated with prolotherapy during the study period, June 1999-May 2006. Patients whose follow-up was 1 year or greater from the last treatment were included, leaving 140 patients available for data analysis. Both pain and QoL scores were significantly improved at least 1 year after the last treatment. There were no differences in outcomes as a result of age, response to xylocaine (lidocaine) injection, insurance coverage, smoking history, or gender.

This study suggests that prolotherapy using a variety of proliferants can be an effective treatment for low back pain from presumed ligamentous dysfunction for some patients when performed by a skilled practitioner.

Source
Watson J, Shay B. Treatment of chronic low back pain: A 1 year or greater follow-up. Journal of Alternative and Complementary Medicine, 2010; 16(9): 951-958.

Case Study 3 - Results
Dextrose prolotherapy appears to be a safe and effective method for treating chronic spinal pain that merits further investigation. Future studies need to consider differences in gender response rates.

Source
Hooper R; Ding M. Retrospective case series on patients with chronic spinal pain treated with dextrose prolotherapy. J Altern Complement Med. 2004; 10(4):670-674.